Matthieu De Kalbermatten
Mulhouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TransEndocardial Injection of Autologous Expanded CD34+ Stem Cells (ProtheraCytes®) after myocardial infarction: Impact on Patients' Quality of Life.
Journal: Stem cell reviews and reports
Published: January 27, 2026
Development and Validation of Flow Cytometry-Based Method to Quantify CD34/CD45+ Cells as a Release Criterion of Clinical-Grade Products for a Phase III Clinical Trial.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: July 11, 2025
Validation of a potency assay for CD34 + cell based therapy.
Journal: Scientific reports
Published: February 20, 2025
Nose-to-brain delivery of stem cells in stroke: the role of extracellular vesicles.
Journal: Stem cells translational medicine
Published: April 11, 2024
Probing Multiple Transplant Delivery Routes of CD+34 Stem Cells for Promoting Behavioral and Histological Benefits in Experimental Ischemic Stroke.
Journal: Stem cells translational medicine
Published: June 05, 2023
Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritis.
Journal: Frontiers in bioengineering and biotechnology
Published: January 24, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026